GENE ONLINE|News &
Medicines for Europe Urges Continued Pharmaceutical Reforms, Including Critical Medicines Act, to Address EU Supply Chain Issues
Medicines for Europe advocates for the ongoing advancement of pharmaceutical reforms, including the Critical Medicines Act. The organization emphasizes the importance of these reforms to bolster the production of essential medicines within the European region. Medicines for Europe’s call to action is in response to supply chain challenges within the EU, and aims to foster innovation. The organization believes that continued progress on pharmaceutical reforms, such as the Critical Medicines Act, is necessary to maintain a reliable supply of essential medicines in Europe.
Newsflash | Powered by GeneOnline AI
Date: May 8, 2025
Author
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
